ArticleBMJ open2024

Phase I/II trial of intracerebral transplantation of autologous bone marrow stem cells combined with recombinant peptide scaffold for patients with chronic intracerebral haemorrhage: a study protocol.

Masahito Kawabori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.